Stock BDMS-R BANGKOK DUSIT MEDICAL SERVICES
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Bangkok Dusit Medical Services Thailand S.E.

Equities

BDMS-R

TH0264010R10

End-of-day quote Thailand S.E.
Other stock markets
 18:00:00 2024-06-06 EDT 		5-day change 1st Jan Change
27.25 THB -0.91% Intraday chart for Bangkok Dusit Medical Services +0.93% -1.80%
05-14 Bangkok Dusit Medical Services Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-24 Bangkok Dusit Medical Services Public Company Limited Announces Appointment of Kongkiat Kespechara as Executive Committee Member CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • The company returns high margins, thereby supporting business profitability.
  • The company is in a robust financial situation considering its net cash and margin position.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Sales forecast by analysts have been recently revised upwards.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • Consensus analysts have strongly revised their opinion of the company over the past 12 months.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • The company benefits from high valuations in earnings multiples.
  • With an enterprise value anticipated at 3.94 times the sales for the current fiscal year, the company turns out to be overvalued.
  • The company appears highly valued given the size of its balance sheet.
  • The valuation of the company is particularly high given the cash flows generated by its activity.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
BANGKOK DUSIT MEDICAL SERVICES Stock Bangkok Dusit Medical Services
-1.80% 11.77B -
AIER EYE HOSPITAL GROUP CO., LTD. Stock Aier Eye Hospital Group Co., Ltd.
-25.47% 15.13B
B+
IHH HEALTHCARE Stock IHH Healthcare
+3.48% 11.71B
B+
ENCOMPASS HEALTH CORPORATION Stock Encompass Health Corporation
+27.17% 8.54B
B
RAMSAY HEALTH CARE LIMITED Stock Ramsay Health Care Limited
-6.29% 7.42B
A-
THE ENSIGN GROUP, INC. Stock The Ensign Group, Inc.
+6.08% 6.72B
B-
MOUWASAT MEDICAL SERVICES COMPANY Stock Mouwasat Medical Services Company
+0.89% 6.02B
D
DALLAH HEALTHCARE COMPANY Stock Dallah Healthcare Company
-4.31% 4.28B -
FORTIS HEALTHCARE LIMITED Stock Fortis Healthcare Limited
+11.12% 4.21B
B+
BURJEEL HOLDINGS PLC Stock Burjeel Holdings PLC
-10.93% 3.93B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
  1. Stock Market
  2. Equities
  3. BDMS Stock
  4. BDMS-R Stock
  5. Ratings Bangkok Dusit Medical Services